Developing PEGylated Reversed D-Peptide as a Novel HER2-Targeted SPECT Imaging Probe for Breast Cancer Detection-Reference-Cited by-同舟云学术

Developing PEGylated Reversed D-Peptide as a Novel HER2-Targeted SPECT Imaging Probe for Breast Cancer Detection

Published:2020-07-13 Issue:8 Volume:31 Page:1971-1980
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Du Shuaifan¹,Luo Chuangwei¹,Yang Guangjie¹,Gao Hannan¹,Wang Yanpu¹,Li Xiaoda²,Zhao Huiyun²,Luo Qi³⁴,Ma Xiaotu³,Shi Jiyun³^ORCID,Wang Fan¹³⁴^ORCID

Affiliation:

1. Medical Isotopes Research Center and Department of Radiation Medicine, State Key Laboratory of Natural and Biomimetic Drugs, School of Basic Medical Sciences, Peking University, Beijing 100191, China

2. Medical and Healthy Analytical Center, Peking University, Beijing 100191, China

3. Key Laboratory of Protein and Peptide Pharmaceuticals, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China

4. Guangzhou Regenerative Medicine and Health Guangdong Laboratory, Guangzhou 510005, China

Funder

Ministry of Science and Technology of the People's Republic of China

Youth Innovation Promotion Association of the Chinese Academy of Sciences

National Natural Science Foundation of China

Chinese Academy of Sciences

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.bioconjchem.0c00334